Pediatrix Medical Group, Inc. (MD) insider trading

By person

36 insiders · 99 transactions

10.0×

Mark S. Ordan holds 10.0 times base salary in stock. $9.76M of shares against $970.01K in salary for 2025.

Salary from the company's own proxy. The shares are what Mark S. Ordan last reported holding, valued at $23.75, the price Common Stock was last bought or sold at on the open market here, on 13 May 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

MEDEL ROGER MD

Director

—

$21.10M (18)

−$21.10M

747,930

0.9205%

$17.76M

−38.6%

FERNANDEZ MICHAEL

Director

$10.76M (6)

—

+$10.76M

605,005

0.7446%

$14.37M

+558.0%

ORDAN MARK S

Chief Executive Officer

—

$5.05M (5) scheduled

−$5.05M

410,884

0.5057%

$9.76M

—

Lopez-Blanco Vivian

Chief Financial Officer

—

$2.85M (4)

−$2.85M

100,590

0.1238%

$2.39M

+24.6%

CALABRO JOSEPH M

President

—

$2.68M (3)

−$2.68M

414,679

0.5104%

$9.85M

+89.6%

Andreano Dominic J

EVP, General Counsel and Secy

—

$2.33M (6)

−$2.33M

189,440

0.2331%

$4.50M

+429.7%

Pepia John C

Principal Accounting Officer

—

$2.04M (14)

−$2.04M

96,666

0.1190%

$2.30M

+181.9%

Goldschmidt, MD Pascal J

Director

$139.68K (1)

$2.15M (5) scheduled

−$2.01M

15,538

0.0191%

$369.03K

+38.1%

GABOS PAUL G

Director

—

$1.49M (1) scheduled

−$1.49M

29,198

0.0359%

$693.45K

+159.4%

Clark David A.

Chief Operating Officer

—

$1.30M (3)

−$1.30M

123,032

0.1514%

$2.92M

+514.4%

Kadre Manuel

Director

$1.21M (1)

—

+$1.21M

129,198

0.1590%

$3.07M

+1,048%

Weis Shirley A

Director

—

$1.11M (3)

−$1.11M

19,095

0.0235%

$453.51K

−48.4%

SOSA ENRIQUE

Director

—

$743.06K (1) scheduled

−$743.06K

37,350

0.0460%

$887.06K

+231.9%

Swift James D

Chief Executive Officer

—

$728.98K (4)

−$728.98K

170,001

0.2092%

$4.04M

+80.9%

Hinson Roger Mack

Pres., PDX & OBX Medical Group

—

$534.39K (2)

−$534.39K

109,457

0.1347%

$2.60M

+33.0%

Richards C Marc

EVP, Chief Financial Officer

—

$504.00K (2)

−$504.00K

175,347

0.2158%

$4.16M

+3,862%

ALVAREZ CESAR L

Director

—

$454.37K (1)

−$454.37K

48,403

0.0596%

$1.15M

+54.9%

WALDEMAR, MD CARLO A

Director

—

$362.19K (1) scheduled

−$362.19K

36,687

0.0452%

$871.32K

+226.0%

Linynsky Laura A

Director

—

$294.62K (2)

−$294.62K

33,900

0.0417%

$805.13K

+99.9%

Rucker Michael A.

Director

—

$240.99K (1)

−$240.99K

66,769

0.0822%

$1.59M

+521.4%

Nikolopoulos Nicholas J

EVP Chf Strategy & Growth Offi

—

$190.18K (1)

−$190.18K

71,954

0.0886%

$1.71M

−46.8%

Moore Mary Ann E

EVP, GC, Chief Admin Off & Sec

—

$150.12K (3)

−$150.12K

189,890

0.2337%

$4.51M

+105.4%

Neeb Don Gregory

EVP, Chief Invest & Strategy

—

137,231

0.1689%

$3.26M

—

Pickert Curtis

EVP, Chief Operating Officer

—

118,318

0.1456%

$2.81M

+304.6%

Wood Lee

EVP, Natl & Market Operations

—

117,281

0.1443%

$2.79M

+240.9%

Rossi Kasandra H

EVP, CFO and Treasurer

—

101,399

0.1248%

$2.41M

+131.7%

SANSONE GUY P

Director

—

87,416

0.1076%

$2.08M

+511.3%

FARBER STEPHEN D

Former Chief Financial Officer

—

78,027

0.0960%

$1.85M

−22.0%

McEachin Thomas

Director

—

73,741

0.0908%

$1.75M

+33.4%

Starcher John M. Jr.

Director

—

73,732

0.0907%

$1.75M

+11,869%

Young Sylvia Jean

Director

—

29,786

0.0367%

$707.42K

—

Barker Karey D

Director

—

22,663

0.0279%

$538.25K

+380.1%

Haddock David

EVP, GC & Corp Sec

—

20,036

0.0247%

$475.86K

—

Newman Kurt Douglas

Director

—

17,405

0.0214%

$413.37K

—

SHALALA DONNA E

Director

—

16,947

0.0209%

$402.49K

+37.7%

MIGOYA CARLOS A.

Director

—

12,062

0.0148%

$286.47K

+64.2%

Individual transactions

Insider

Date

Role

Action

Price

Amount

ORDAN MARK S

30 Aug 2021

Chief Executive Officer

Sold after exercise

95,000

$35.09

$3.33M

Pepia John C

22 May 2018

Principal Accounting Officer

Sold after exercise

3,000

$46.43

$139.29K

Pepia John C

13 Mar 2018

Principal Accounting Officer

Sold after exercise

3,000

$58.35

$175.06K

Pepia John C

12 Dec 2017

Principal Accounting Officer

Sold after exercise

3,000

$51.58

$154.74K

Pepia John C

12 Sep 2017

Principal Accounting Officer

Sold after exercise

3,000

$42.85

$128.55K

SOSA ENRIQUE

23 Feb 2017

Director

Sold after exercise

10,668

$69.65

$743.06K

Andreano Dominic J

16 Feb 2017

SVP, General Counsel and Secy

Sold after exercise

6,000

$69.59

$417.53K

GABOS PAUL G

16 Feb 2017

Director

Sold after exercise

21,336

$69.63

$1.49M

Pepia John C

16 Feb 2017

Principal Accounting Officer

Sold after exercise

1,500

$69.58

$104.37K

Pepia John C

16 Feb 2017

Principal Accounting Officer

Sold after exercise

1,000

$69.58

$69.58K

Goldschmidt, MD Pascal J

10 Feb 2017

Director

Sold after exercise

25,294

$67.82

$1.72M

WALDEMAR, MD CARLO A

9 Feb 2017

Director

Sold after exercise

5,334

$67.90

$362.19K

Show all 99 transactions →

Pediatrix Medical Group, Inc.

By person

Individual transactions

What was left out